Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published April 2, 2018 | Submitted + Published + Supplemental Material
Journal Article Open

A toolbox of anti–mouse and anti–rabbit IgG secondary nanobodies

Abstract

Polyclonal anti–immunoglobulin G (anti-IgG) secondary antibodies are essential tools for many molecular biology techniques and diagnostic tests. Their animal-based production is, however, a major ethical problem. Here, we introduce a sustainable alternative, namely nanobodies against all mouse IgG subclasses and rabbit IgG. They can be produced at large scale in Escherichia coli and could thus make secondary antibody production in animals obsolete. Their recombinant nature allows fusion with affinity tags or reporter enzymes as well as efficient maleimide chemistry for fluorophore coupling. We demonstrate their superior performance in Western blotting, in both peroxidase- and fluorophore-linked form. Their site-specific labeling with multiple fluorophores creates bright imaging reagents for confocal and superresolution microscopy with much smaller label displacement than traditional secondary antibodies. They also enable simpler and faster immunostaining protocols, and allow multitarget localization with primary IgGs from the same species and of the same class.

Additional Information

© 2018 Pleiner et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https ://creativecommons .org /licenses /by /4 .0 /). Submitted: 28 September 2017; Revision received 29 November 2017; Accepted: 7 December 2017; Published Online: 20 December, 2017. We thank Ulrike Teichmann and Rolf Rümenapf for alpaca care and immunization; Jens Krull, Heinz-Jürgen Dehne, Gabriele Hawlitscheck, Renate Rees, Jürgen Schünemann, and Tanja Gilat for excellent technical assistance; Philip Gunkel, Volker Cordes, and Mary Osborn for advice and antibodies (Max Planck Institute for Biophysical Chemistry, Göttingen, Germany); Bastian B. Hülsmann for anti-Xenopus Nup nanobodies and antigens (Max Planck Institute for Biophysical Chemistry, Göttingen, Germany); and Nataliia Naumenko and Trevor Huyton for critical reading of the manuscript. We thank Max-Planck-Gesellschaft and the Deutsche Forschungsgemeinschaft (SFB1190) for funding this work. T. Pleiner and D. Görlich are inventors on a European patent application encompassing the nanobodies described in this article. The authors declare no further conflict of interest. Author contributions: T. Pleiner: conception and design, acquisition of data, analysis and interpretation of data, drafting and revising the article; M. Bates: experiment design, acquisition of data, analysis and interpretation of data, drafting and revising the article; D. Görlich: conception and design, analysis and interpretation of data, drafting and revising the article.

Attached Files

Published - 1143.full.pdf

Submitted - 209742.full.pdf

Supplemental Material - JCB_201709115_TableS1.xlsx

Supplemental Material - JCB_201709115_sm.pdf

Files

209742.full.pdf
Files (10.5 MB)
Name Size Download all
md5:23504112bcf8e074b315743491d62029
6.5 MB Preview Download
md5:acb62bec95689f8f5c3de4fecacd187d
2.3 MB Preview Download
md5:7579a2026b975a27c8a37d403f9e71e1
13.5 kB Download
md5:8f1b06ec52a6756dcba6d5ddce8b4ac2
1.7 MB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 20, 2023